{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:43:29Z","timestamp":1790837009046,"version":"4.1.0"},"reference-count":26,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T00:00:00Z","timestamp":1715126400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T00:00:00Z","timestamp":1715126400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100004721","name":"The University of Tokyo","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100004721","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur Arch Otorhinolaryngol"],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Introduction<\/jats:title>\n                <jats:p>Hypopharyngeal squamous cell carcinoma (HSCC) is often undetected until advanced stages, which contributes to poor survival rates. Recent advances in diagnostic techniques have enhanced the feasibility of early detection, and this study evaluated the efficacy and safety of radical radiotherapy that specifically targets early stage HSCC.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>This retrospective cohort study consecutively analyzed patients with clinical stage I or II HSCC between December 2008 and February 2023. These patients underwent radical radiotherapy with a uniform dose of 70 Gy delivered in 35 fractions to the primary site, followed by elective nodal irradiation. We assessed clinical outcomes, including overall survival (OS), disease-free survival (DFS), and 5-year locoregional control (LRC). Multivariate analyses were performed to identify the independent prognostic factors for OS.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>The 5-year OS rate of the entire cohort was 80.7% (95% confidence interval [CI]\u2009=\u200966.5\u201389.4%), with no significant difference between patients with clinical stage I and II HSCC. Stratified by subsite, the 5-year OS for pyriform sinus, posterior pharyngeal wall, and postcricoid region were 81.6, 68.2, and 100%, respectively. The ECOG-Performance status (PS) was identified as an independent risk factor for OS (hazard ratio [HR]\u2009=\u20098.457; 95% CI 1.325\u201353.970; p\u2009=\u20090.024). DFS at 5 years was 66.4%, with local recurrence being the most frequent, and LRC rate at 5 years was 79.3%. Acute and late-phase toxicities were predominantly mild to moderate, with no grade 3 or higher toxicities reported.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This study supports radical radiotherapy as an effective approach for optimal tumor control in patients with early stage HSCC. Despite the limitations of this study, including its retrospective design and single-center confinement, our results revealed the effectiveness and feasibility of radical radiotherapy in the management of early stage HSCC.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00405-024-08722-w","type":"journal-article","created":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T17:01:48Z","timestamp":1715187708000},"page":"4401-4407","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Early-stage hypopharyngeal squamous cell carcinoma treated with radical radiotherapy at a uniform dose of 70\u00a0Gy in 35 fractions: a single-center study"],"prefix":"10.1007","volume":"281","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4393-1828","authenticated-orcid":false,"given":"Atsuto","family":"Katano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideomi","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,5,8]]},"reference":[{"key":"8722_CR1","doi-asserted-by":"publisher","first-page":"2130","DOI":"10.1016\/j.ejca.2015.07.043","volume":"51","author":"G Gatta","year":"2015","unstructured":"Gatta G, Botta L, S\u00e1nchez MJ, Anderson LA, Pierannunzio D, Licitra L (2015) Prognoses and improvement for head and neck cancers diagnosed in Europe in early 2000s: the EUROCARE-5 population-based study. Eur J Cancer 51:2130\u20132143. https:\/\/doi.org\/10.1016\/j.ejca.2015.07.043","journal-title":"Eur J Cancer"},{"key":"8722_CR2","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.oraloncology.2018.09.025","volume":"86","author":"JC Garneau","year":"2018","unstructured":"Garneau JC, Bakst RL, Miles BA (2018) Hypopharyngeal cancer: a state of the art review. Oral Oncol 86:244\u2013250. https:\/\/doi.org\/10.1016\/j.oraloncology.2018.09.025","journal-title":"Oral Oncol"},{"key":"8722_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000492299","volume":"83","author":"PJ Bradley","year":"2019","unstructured":"Bradley PJ (2019) Epidemiology of hypopharyngeal cancer. Adv Otorhinolaryngol 83:1\u201314. https:\/\/doi.org\/10.1159\/000492299","journal-title":"Adv Otorhinolaryngol"},{"key":"8722_CR4","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1038\/s41598-017-19069-0","volume":"8","author":"H Zhou","year":"2018","unstructured":"Zhou H, Zhang J, Guo L, Nie J, Zhu C, Ma X (2018) The value of narrow band imaging in diagnosis of head and neck cancer: a meta-analysis. Sci Rep 8:515. https:\/\/doi.org\/10.1038\/s41598-017-19069-0","journal-title":"Sci Rep"},{"key":"8722_CR5","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/j.anorl.2021.03.004","volume":"138","author":"E Chabrillac","year":"2021","unstructured":"Chabrillac E, Dupret-Bories A, Vairel B, Woisard V, De Bonnecaze G, Vergez S (2021) Narrow-band imaging in oncologic otorhinolaryngology: state of the art. Eur Ann Otorhinolaryngol Head Neck Dis 138:451\u2013458. https:\/\/doi.org\/10.1016\/j.anorl.2021.03.004","journal-title":"Eur Ann Otorhinolaryngol Head Neck Dis"},{"key":"8722_CR6","doi-asserted-by":"publisher","first-page":"1934","DOI":"10.1038\/s41416-021-01386-x","volume":"124","author":"H Mahmood","year":"2021","unstructured":"Mahmood H, Shaban M, Rajpoot N, Khurram SA (2021) Artificial Intelligence-based methods in head and neck cancer diagnosis: an overview. Br J Cancer 124:1934\u20131940. https:\/\/doi.org\/10.1038\/s41416-021-01386-x","journal-title":"Br J Cancer"},{"key":"8722_CR7","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1002\/hed.21613","volume":"34","author":"RP Takes","year":"2012","unstructured":"Takes RP, Strojan P, Silver CE et al (2012) Current trends in initial management of hypopharyngeal cancer: the declining use of open surgery. Head Neck 34:270\u2013281. https:\/\/doi.org\/10.1002\/hed.21613","journal-title":"Head Neck"},{"key":"8722_CR8","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13194912","author":"G Anderson","year":"2021","unstructured":"Anderson G, Ebadi M, Vo K, Novak J, Govindarajan A, Amini A (2021) An updated review on head and neck cancer treatment with radiation therapy. Cancers (Basel). https:\/\/doi.org\/10.3390\/cancers13194912","journal-title":"Cancers (Basel)"},{"key":"8722_CR9","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.1002\/hed.26793","volume":"43","author":"N Burbure","year":"2021","unstructured":"Burbure N, Handorf E, Ridge JA et al (2021) Prognostic significance of human papillomavirus status and treatment modality in hypopharyngeal cancer. Head Neck 43:3042\u20133052. https:\/\/doi.org\/10.1002\/hed.26793","journal-title":"Head Neck"},{"key":"8722_CR10","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1002\/hed.24752","volume":"41","author":"DI Kwon","year":"2019","unstructured":"Kwon DI, Miles BA (2019) Hypopharyngeal carcinoma: do you know your guidelines? Head Neck 41:569\u2013576. https:\/\/doi.org\/10.1002\/hed.24752","journal-title":"Head Neck"},{"key":"8722_CR11","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.radonc.2013.10.010","volume":"110","author":"V Gr\u00e9goire","year":"2014","unstructured":"Gr\u00e9goire V, Ang K, Budach W et al (2014) Delineation of the neck node levels for head and neck tumors: a 2013 update. DAHANCA, EORTC, HKNPCSG, NCIC CTG, NCRI, RTOG, TROG consensus guidelines. Radiother Oncol 110:172\u2013181. https:\/\/doi.org\/10.1016\/j.radonc.2013.10.010","journal-title":"Radiother Oncol"},{"key":"8722_CR12","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.radonc.2017.10.016","volume":"126","author":"V Gr\u00e9goire","year":"2018","unstructured":"Gr\u00e9goire V, Evans M, Le QT et al (2018) Delineation of the primary tumour Clinical Target Volumes (CTV-P) in laryngeal, hypopharyngeal, oropharyngeal and oral cavity squamous cell carcinoma: AIRO, CACA, DAHANCA, EORTC, GEORCC, GORTEC, HKNPCSG, HNCIG, IAG-KHT, LPRHHT, NCIC CTG, NCRI, NRG Oncology, PHNS, SBRT, SOMERA, SRO, SSHNO, TROG consensus guidelines. Radiother Oncol 126:3\u201324. https:\/\/doi.org\/10.1016\/j.radonc.2017.10.016","journal-title":"Radiother Oncol"},{"key":"8722_CR13","doi-asserted-by":"publisher","first-page":"2001","DOI":"10.1007\/s00405-014-3132-1","volume":"272","author":"K Sato","year":"2015","unstructured":"Sato K, Kubota A, Furukawa M et al (2015) Definitive radiotherapy for early-stage hypopharyngeal squamous cell carcinoma. Eur Arch Otorhinolaryngol 272:2001\u20132006. https:\/\/doi.org\/10.1007\/s00405-014-3132-1","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"8722_CR14","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1093\/jrr\/rrs044","volume":"53","author":"H Nishimura","year":"2012","unstructured":"Nishimura H, Sasaki R, Yoshida K et al (2012) Radiotherapy for stage I or II hypopharyngeal carcinoma. J Radiat Res 53:892\u2013899. https:\/\/doi.org\/10.1093\/jrr\/rrs044","journal-title":"J Radiat Res"},{"key":"8722_CR15","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.ijrobp.2006.02.001","volume":"65","author":"K Nakamura","year":"2006","unstructured":"Nakamura K, Shioyama Y, Kawashima M et al (2006) Multi-institutional analysis of early squamous cell carcinoma of the hypopharynx treated with radical radiotherapy. Int J Radiat Oncol Biol Phys 65:1045\u20131050. https:\/\/doi.org\/10.1016\/j.ijrobp.2006.02.001","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"8722_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12031237","author":"A Bozec","year":"2023","unstructured":"Bozec A, Poissonnet G, Dassonville O, Culi\u00e9 D (2023) Current therapeutic strategies for patients with hypopharyngeal carcinoma: oncologic and functional outcomes. J Clin Med. https:\/\/doi.org\/10.3390\/jcm12031237","journal-title":"J Clin Med"},{"key":"8722_CR17","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1016\/j.oraloncology.2018.09.014","volume":"86","author":"P Mazerolle","year":"2018","unstructured":"Mazerolle P, Philouze P, Garrel R et al (2018) Oncological and functional outcomes of trans-oral robotic surgery for pyriform sinus carcinoma: a French GETTEC group study. Oral Oncol 86:165\u2013170. https:\/\/doi.org\/10.1016\/j.oraloncology.2018.09.014","journal-title":"Oral Oncol"},{"key":"8722_CR18","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s00405-022-07622-1","volume":"280","author":"R Casanueva","year":"2023","unstructured":"Casanueva R, L\u00f3pez F, Garc\u00eda-Cabo P, \u00c1lvarez-Marcos C, Llorente JL, Rodrigo JP (2023) Oncological and functional outcomes of transoral laser surgery for hypopharyngeal carcinoma. Eur Arch Otorhinolaryngol 280:829\u2013837. https:\/\/doi.org\/10.1007\/s00405-022-07622-1","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"8722_CR19","doi-asserted-by":"publisher","first-page":"E807","DOI":"10.1002\/lary.28821","volume":"131","author":"K Thakur","year":"2021","unstructured":"Thakur K, Singh CA, Thakar A et al (2021) Prevalence of synchronous ESCN in head and neck cancer: a single-institution perspective. Laryngoscope 131:E807-e814. https:\/\/doi.org\/10.1002\/lary.28821","journal-title":"Laryngoscope"},{"key":"8722_CR20","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/s12885-018-5231-7","volume":"19","author":"T Iwatsubo","year":"2019","unstructured":"Iwatsubo T, Ishihara R, Morishima T et al (2019) Impact of age at diagnosis of head and neck cancer on incidence of metachronous cancer. BMC Cancer 19:3. https:\/\/doi.org\/10.1186\/s12885-018-5231-7","journal-title":"BMC Cancer"},{"key":"8722_CR21","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1038\/s41598-020-57630-6","volume":"10","author":"CM Tseng","year":"2020","unstructured":"Tseng CM, Wang HH, Lee CT et al (2020) A nationwide population-based study to access the risk of metachronous esophageal cancers in head and neck cancer survivors. Sci Rep 10:884. https:\/\/doi.org\/10.1038\/s41598-020-57630-6","journal-title":"Sci Rep"},{"key":"8722_CR22","doi-asserted-by":"publisher","first-page":"1281","DOI":"10.21873\/invivo.13206","volume":"37","author":"K Sato","year":"2023","unstructured":"Sato K, Hatakeyama H, Okada H et al (2023) Fibrinogen-to-lymphocyte ratio predicts the outcomes of hypopharyngeal squamous cell carcinoma treated with definitive radiotherapy. In Vivo 37:1281\u20131289. https:\/\/doi.org\/10.21873\/invivo.13206","journal-title":"In Vivo"},{"key":"8722_CR23","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1093\/jrr\/rrad043","volume":"64","author":"H Ishinaga","year":"2023","unstructured":"Ishinaga H, Okugawa Y, Hou B et al (2023) The role of miR-21 as a predictive biomarker and a potential target to improve the effects of chemoradiotherapy against head and neck squamous cell carcinoma. J Radiat Res 64:668\u2013676. https:\/\/doi.org\/10.1093\/jrr\/rrad043","journal-title":"J Radiat Res"},{"key":"8722_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctro.2023.100590","volume":"39","author":"C Bang","year":"2023","unstructured":"Bang C, Bernard G, Le WT, Lalonde A, Kadoury S, Bahig H (2023) Artificial intelligence to predict outcomes of head and neck radiotherapy. Clin Transl Radiat Oncol 39:100590. https:\/\/doi.org\/10.1016\/j.ctro.2023.100590","journal-title":"Clin Transl Radiat Oncol"},{"key":"8722_CR25","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1001\/jamaoncol.2015.3113","volume":"1","author":"HJ West","year":"2015","unstructured":"West HJ, Jin JO (2015) JAMA Oncology Patient Page. Performance status in patients with cancer. JAMA Oncol 1:998. https:\/\/doi.org\/10.1001\/jamaoncol.2015.3113","journal-title":"JAMA Oncol"},{"key":"8722_CR26","doi-asserted-by":"publisher","first-page":"4104","DOI":"10.1002\/cam4.4722","volume":"11","author":"C Chalker","year":"2022","unstructured":"Chalker C, Voutsinas JM, Wu QV et al (2022) Performance status (PS) as a predictor of poor response to immune checkpoint inhibitors (ICI) in recurrent\/metastatic head and neck cancer (RMHNSCC) patients. Cancer Med 11:4104\u20134111. https:\/\/doi.org\/10.1002\/cam4.4722","journal-title":"Cancer Med"}],"container-title":["European Archives of Oto-Rhino-Laryngology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-024-08722-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00405-024-08722-w\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00405-024-08722-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T19:46:44Z","timestamp":1721764004000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00405-024-08722-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,8]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["8722"],"URL":"https:\/\/doi.org\/10.1007\/s00405-024-08722-w","relation":{},"ISSN":["0937-4477","1434-4726"],"issn-type":[{"value":"0937-4477","type":"print"},{"value":"1434-4726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,5,8]]},"assertion":[{"value":"14 February 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}